Nick Tate
Nick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.
Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.
As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.
His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.
His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.
Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.
Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.
Nick Tate's Articles
Tesla & Teladoc: 2 Stocks Show You Why to Hold January 27, 2022 Bold Profits Daily, Investing, Stocks
- Here’s why to stay bullish through volatility and hold your America 2.0 stocks.
Why Invest in the “Future of Food”? January 6, 2022 Bold Profits Daily, Investing, Investment Opportunities, Trading Strategies
- To get real, lasting growth, you need innovation. Take something from the old world and make it more efficient, easier, sustainable in the new world.
2022 Telehealth-Trend: Invest for 63-Fold Growth December 16, 2021 Bold Profits Daily, Investment Opportunities, Technology
- Here’s a sign that telemedicine is here to stay — and a great investment to make now. 
Beyond Turkey? November 25, 2021 Bold Profits Daily, Investment Opportunities
- This Thanksgiving is showcasing the growing meatless market — the future-of-food trend. Here’s the driving force (and one buy) for it.
3 Biotech Innovations Driving America 2.0 Stocks Up November 4, 2021 Bold Profits Daily, Investment Opportunities, Technology
- The genetics-biotech revolution is remaking our $16 trillion health care industry. Here’s how to upgrade your portfolio for America 2.0 medicine. 
3D-Printed Vaccine: New Catalyst for Stocks October 14, 2021 Bold Profits Daily, Investment Opportunities, Technology
- A new 3D-printing advance will change how billions of vaccines are delivered each year — that’s billions with a “B”! — showcasing a massive opportunity for you. 
Why Invest in 3D Printing? Life-Changing Reasons (X2) September 23, 2021 Bold Profits Daily, Investment Opportunities, Technology
- This will go down in the medical history books for sure, but it also showcases an opportunity for America 2.0 investors like you. 
3D Printing + Precision Medicine = Profits! September 2, 2021 Bold Profits Daily, Investment Opportunities, Stocks, Technology
- This is a brand-new 3D printing and precision medicine breakthrough! Give yourself as many chances as you can to win.
Olympic Gold-Medal Winner: 3D Printing! August 12, 2021 Bold Profits Daily, Investment Opportunities, Stocks
- This year’s Olympics didn’t just showcase the world’s most elite athletes … it set 3D printing up front and center. And here’s your way in before the 5X rise!
No. 1 Stock for Holy Grail of Medicine July 22, 2021 Bold Profits Daily, Investing, Investment Opportunities, Stocks
- It’s the Holy Grail of medicine: An America 2.0 biotech company working on a once-in-a-lifetime flu vaccine. Get the game-changing stock now.
